Background: Developing the research capacity of Low and Middle Income Countries (LMICs) has been shown to be one of the key ways that international health programs and health research can create sustained benefit in these countries. The aim of this study was to examine trends in first-authorship for researchers from LMIC institutions (LMIC firstauthors) over the period 1990-2013.
Introduction
There has been an explosive growth in global commitments for health and human development in low-and middle-income countries (LMICs) over the last 15 years, most notably demonstrated in the establishment of the Millennium Development Goals (MDGs) in 2000.(1)- (2) There is evidence that a focus on building research capacity has had an important role in strengthening health systems, the development, implementation and evaluation of health programs, and providing the evidence base to support population health planning and responses to health crises. (3) (4) (5) (6) (7) (8) Therefore developing LMIC research capacity is one of the key ways that international health programs and health research can create sustained benefit in these countries. (5) In particular national health research capacity is a critical component that enables LMICs to identify and progress their national health priorities. (5) Despite the increased understanding of the importance of research capacity building, few studies have examined changes in research capacity since 2000. A 2005 international survey of research capacity in LMICs identified significant deficits in all but one of the 12 countries surveyed. (3) In particular the survey found that data on financing of research was lacking for most countries. There is some evidence of positive changes to research capacity within the remit of specific initiatives; (6, 8) however there is also evidence that longstanding training initiatives have failed to effectively reduce workforce shortages in health research. (9) Randomised controlled trials (RCT) are considered the best experimental design for assessing LMICs. (10, 12) In this context, the aim of this study was to examine trends in first-authorship by researchers from LMIC institutions over time (LMIC first-authors hereafter). If capacity building initiatives in recent years have been successful, then the number and proportion of articles with first-authors from LMIC institutions would be expected to have increased. To this end we systematically reviewed research articles about RCTs focused on HIV/AIDS, Malaria, and Tuberculosis (TB) conducted in LMICs from 1990-2013 and identified the institutional affiliations of the authors.
Methods

Inclusion and exclusion criteria
The study focused on RCTs because the requirement to register the studies means that they are clearly identifiable. Studies were included on the following criteria:
(1) Published in a peer-reviewed journal in the period from January 1990 to December
2013;
(2) Conducted in a LMIC, or LMICs in the case of a multi-country RCT, with recruitment of participants exclusively from the local population;
(3) Outcome variable related to HIV, Malaria or TB;
(4) Evidence of randomisation of the intervention either individual or group assignment;
We excluded studies if the source RCTs did not describe methods of random allocation or participant characteristics at baseline, failed to disclose funding sources or author affiliations, or were conducted in multiple countries. Terminated RCTs were included, subject to the same criteria as above.
Search strategy and data extraction
We There were 6405 unique citations with information on authors and publication year were identified from the databases. Once the inclusion and exclusion criteria were applied there were a total 1583 individual papers reporting baseline results and having funding disclosure, sourced from single-and multi-country RCTs published from 1990 to 2013. Most exclusions occurred because the study was not an RCT (93%), a further 4% were excluded because of lack of funding disclosure, and 3% were excluded because they reported on multi-country studies.
Two of the authors (AR and LE) extracted information pertaining to study country, year of publication, disease, intervention type, first-author, co-authors, and funding source categories as outlined above. Disagreements in classification were resolved involving a third person (MK). An Excel spreadsheet was developed to code information and execute the algorithms for classifying types of first and co-authorship as well as funding source. All studies were coded into 14 regional sub-groupings: five in Africa (Eastern, Middle, Northern, Southern, and Western Africa), three in the Americas (South, Central, and North America), five in Asia (Central, Eastern, Southern, South-Eastern, and Western Asia), and one in Oceania (Melanesia).
Analysis
Frequencies were examined for funder, disease, intervention type, region, and year of publication (before or after 2000) by LMIC first-authorship. Chi-square analysis was used to examine differences between groups.
Multiple Poisson regression with a log-link function was performed to examine the effect of funding source, publication year, intervention type, and regions on the probability of local first-authorship (yes/no) for single-country studies. The robust variance estimator was used to account for clustering among articles associated with the same study. The Wald test was used to evaluate the interaction terms for all funding categories in the adjusted models for all diseases in combination or singly. The probability of LMIC first-authorship by funding sources and year were plotted using the margins and marginsplot commands in STATA version 13,(13) with a caveat that the upper limit of probabilities could exceed one (i.e., certainty) due to the equal interval space emanating from the data points to the lower and upper boundaries of the confidence interval (14).
A sensitivity analysis was conducted to assess the impact of potential misclassifications of first-authors on the results. For each disease the impact of misclassifications was assessed by assuming 20%, 50%, and 80% of non-cases for positive findings and cases for negative findings. Top and bottom ranges for the outcome group were varied.
Results
Overall, it was found that 49.8% of the 1593 identified articles had LMIC first-authors. [ Figures 1 and 2 about here] Table 1 shows the relationship between each of the various identified study characteristics and whether or not the first author was affiliated with an institution in a LMIC. It can be seen that the percentage of articles with LMIC first-authorship was higher for articles published for HIV/AIDS ( 2 = 4·8, p = 0·03) but remained the same for TB ( 2 = 1·3, p = 0·25) and
Malaria ( 2 = 0·01, p = 0·92).
[ Table 1 about here] The stratified relative risk results showed that LMIC first-authorship was associated with disease, funding type, year of publication, intervention type, and region (see Table 2 ). In particular, LMIC first-authorship was less likely in studies of HIV/AIDS when compared with studies investigating TB and Malaria. Furthermore, LMIC first-authorship was twice as likely among studies that were fully LMIC funded compared to studies with non-US HIC funding;
while LMIC first-authorship was less likely for US funded research compared to non-US HIC funded research. Research addressing preventive and diagnostic interventions and, to a lesser extent, behavioural interventions was associated with lower levels of LMIC first-authorship than pharmaceutical and vaccine research. Finally, LMIC first-authorship was more likely in the Americas, Asia, and Oceania than in Africa.
[ Table 2 about here] [ Figure 3 about here] A sensitivity analysis demonstrated that the results of the analysis were robust against misclassifications of local authorship from 20-80% (see online annex).
Discussion
Over the last 25 years debate around global health research has shifted from questioning the value of health research for LMIC (12) The relationship between LMIC first-authorship and different funder types is most likely due to funder's influence on who receives grants rather than on a direct effect on authorship per se. While one solution would be for a greater proportion of research to be funded by LMIC countries, this solution is unlikely to be practicable in the short term. A more effective approach may be for HIC funders of LMIC research to address explicit (e.g., restrictions based on nationality) and implicit barriers (e.g., failure to consider performance against opportunity). The highly competitive nature of research funding means that funders have a great deal of leverage to shift practice by changing requirements for applications and around research collaborations to maximise equity.(14) Ultimately the contribution of research to human health is likely to be optimised if the best ideas are funded wherever they arise.
Previous research suggests that there may be a number of structural barriers to LMIC researchers assuming leadership roles including a lack of a secure institutional base which means they may lack the support required to develop funding applications. The main limitations of the study were around the classification of research funders and research institutions. These classifications were highly reliant on the quality of the information provided in the research articles. The institutional affiliations are clearly an imperfect proxy for a researcher's country of origin but they do provide important information about fund holding and are therefore a reasonable proxy in relation to capacity building. Indeed the sensitivity analysis suggested that both these limitations would have a minimal impact on the results. We tracked both changes in the number and proportion of articles that are LMIC first-authored. We did not base the analysis solely on numbers of articles because of cases like Malaria where, although the number of articles with LMIC firstauthors increased, the proportion of articles decreased. Senior authorship also has special status in the research literature; however the position of senior author varies between disciplines. We focused on first-authorship because we considered a range of different types of RCTs and wanted to ensure that the selected indicator had consistency across disciplines.
Additionally in this regard, it should also be noted that there remains uncertainty as to whether the increases in first authorship were due to funding that goes to LMICs or because of the growing collaborations between institutions in the HICs and LMICs.
A further limitation is the specific focus on RCTs. In particular this is because capacity building strategies in LMICs often target graduate students, who generally do not undertake RCTs due to limited funding and time constraints. This means that it is possible that many LMIC graduate student papers would not have been included in the analysis and therefore some of the impacts of capacity building strategies may be underestimated. In addition first authorship on RCTs would mostly include medical doctors with reasonable experience. Other professions, such as epidemiology, statistics, laboratory sciences, social research etc. would not appear as first authors on these articles but they may appear as middle authors. It should, therefore, be noted that this group of researchers (non-randomized studies) comprise of a good proportion of the impact of capacity building and hence the criteria used in this study may grossly underestimate the impact.
This study is the first to our knowledge that has tracked trends in LMIC first-authorship.
LMIC first-authorship has increased in absolute terms in the post-2000 period. This was due to increased LMIC first-authorship in fully LMIC funded research. Similar trends were not observed in HIC funded research. This suggests that more inclusive policies by international funders are important to developing greater research leadership in LMICs. 
